Compound ID | 258

Research Program: (259C)

Class: DNA synthesis inhibitor

Agent Type: Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: DNA synthesis inhibitor. Pol IIIC and Topoisomerase IV inhibitor
Target Pathogen: Active against 6-anilinouracils- or fluoroquinolone-resistant Gram positive bacteria
Institute where first reported: Microbiotix, US; GLSynthesis, USA
Year first mentioned: 2003
Development status: Experimental
External links:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.